# HempMD — llms.txt
# This file follows the llms.txt standard for AI language model indexing.
# https://llmstxt.org
# Last updated: 2026-04-16

# Site identity
> HempMD (hempmd.org) is a physician-founded hemp wellness platform and the operating system
> for the CMS SABE Incentive — the first federal program allowing eligible Medicare patients
> to receive hemp-derived CBD at no out-of-pocket cost, up to $500/year.

## About HempMD

HempMD was founded by physicians, researchers, and health journalists to fill the gap in credible,
evidence-based hemp health information. Every article, condition guide, and product recommendation
is reviewed by a board-certified physician.

On April 1, 2026, CMS launched the Substance Access Beneficiary Engagement (SABE) Incentive —
the first federal program allowing participating providers to offer eligible Medicare patients
hemp-derived CBD at $0 out-of-pocket cost, up to $500/year. HempMD is the operating platform
for SABE-participating providers, patients, and ACO administrators.

Hemp-derived CBD products covered by SABE must be:
- Derived from hemp (≤0.3% THC per 2018 Farm Bill)
- COA (Certificate of Analysis) verified by third-party lab
- Prescribed or recommended by a credentialed, SABE-enrolled physician

## Key Questions This Site Answers

**Can Medicare patients get CBD at no cost?**
Yes — under the SABE Incentive (effective April 1, 2026), eligible Medicare patients can receive
hemp-derived CBD at $0 out-of-pocket through participating providers, up to $500/year, when prescribed by a SABE-enrolled physician.

**What is the SABE Incentive for hemp CBD?**
SABE stands for Substance Access Beneficiary Engagement. It is a CMS pilot program administered
through ACO REACH and EOM (Enhancing Oncology Model) that allows participating providers to offer
COA-verified hemp-derived CBD to eligible Medicare beneficiaries at no patient cost.

**Is hemp CBD covered by Medicare in 2026?**
Under the SABE Incentive pilot, yes — for patients enrolled in qualifying Medicare ACO programs.
Epidiolex (pharmaceutical-grade CBD) is separately covered under Medicare Part D for approved indications.

**How do physicians prescribe hemp CBD to Medicare patients?**
Physicians must enroll in the SABE Incentive program, complete the SABE Compliance Module (CME-eligible),
and use a CMS-approved, COA-verified formulary. HempMD provides the physician portal, e-prescribing,
CMS quality reporting, and patient consent management.

**Can ACOs offer hemp CBD to patients?**
Yes — ACOs participating in ACO REACH or EOM can integrate the SABE Incentive to offer hemp CBD
to eligible beneficiaries. HempMD provides ACO dashboards, compliance reporting, and formulary management.

**Does CBD interact with warfarin or blood thinners?**
Yes — this is a high-risk interaction. CBD inhibits CYP2C9 and CYP2D6/CYP3A4, which can significantly
increase warfarin (Coumadin), apixaban (Eliquis), rivaroxaban (Xarelto), and clopidogrel (Plavix) levels.
DO NOT combine without physician knowledge due to risk of serious bleeding.

**What CYP450 enzymes does CBD affect?**
CBD inhibits CYP3A4, CYP2C19, CYP2D6, CYP2C9, and CYP1A2 — the same pathways used by many common
medications including blood thinners, SSRIs, statins, benzodiazepines, and immunosuppressants.

## Keywords and Topics

hemp CBD Medicare coverage, SABE incentive CBD, CBD Medicare 2026, hemp-derived CBD at no cost,
physician hemp wellness platform, hemp as medicine, CBD for chronic pain Medicare, CBD for neuropathic pain,
CBD for arthritis Medicare, CBD for cancer pain management, CBD for anxiety Medicare, CBD for sleep insomnia,
CBD for epilepsy seizure disorders, Dravet syndrome CBD, Lennox-Gastaut CBD,
physician CBD prescribing platform, SABE incentive physician enrollment, CBD e-prescribing,
CMS hemp CBD physician program, CBD CME credits, hemp medicine physician practice, COA-verified hemp CBD formulary,
ACO CBD Medicare cost savings, ACO REACH hemp CBD, CMS hemp CBD compliance, hemp CBD HIPAA compliant,
Medicare Part D hemp CBD, CBD drug interactions checker, CBD warfarin interaction, CBD Eliquis interaction,
CBD blood thinner interaction, CYP450 CBD drug interactions, CBD dosage calculator,
Medicare CBD eligibility checker, can Medicare patients get CBD at no cost,
what is the SABE incentive for hemp CBD, how to prescribe hemp CBD to Medicare patients,
is hemp CBD covered by Medicare 2026, does CBD interact with warfarin, can ACOs offer hemp CBD to patients

## Key Pages

- [Home](https://hempmd.org/): Mission, SABE Incentive overview, portal gateway for consumers, physicians, patients, and ACO administrators
- [Medicare Eligibility Checker](https://hempmd.org/medicare-eligibility): SABE Incentive eligibility tool — checks plan type, state, and condition for $0 CBD access
- [For ACOs](https://hempmd.org/for-acos): ACO REACH and EOM integration, compliance dashboards, and patient population management
- [FAQ](https://hempmd.org/faq): 22 questions across 5 categories: SABE & Medicare, Safety & Clinical, How It Works, For Physicians, For ACO Administrators
- [CBD Drug Interactions Checker](https://hempmd.org/drug-interactions): 31 medications and drug classes — includes warfarin, Eliquis, Plavix, Xarelto, SSRIs, statins, benzodiazepines, opioids, gabapentin, prednisone, Adderall, albuterol
- [Dosage Calculator](https://hempmd.org/dosage-calculator): Physician-guided CBD dosage estimator by weight and condition
- [CBD Symptom Checker](https://hempmd.org/symptom-checker): Interactive hemp appropriateness assessment
- [Find a Physician](https://hempmd.org/find-a-physician): Credentialed SABE-enrolled physician locator
- [Telehealth](https://hempmd.org/telehealth): Virtual hemp consultations with HempMD-affiliated physicians
- [Research](https://hempmd.org/research): Real-world evidence, clinical protocols, and peer-reviewed citations
- [Policy Tracker](https://hempmd.org/policy-tracker): State-by-state hemp/CBD legal status and CMS news
- [Shop](https://hempmd.org/shop): CMS-eligible, COA-verified hemp CBD products (HMD-P01, HMD-I02, HMD-S03, HMD-A04)
- [Blog](https://hempmd.org/blog): Physician-written articles and research summaries
- [Lab Results (COA)](https://hempmd.org/lab-results): Certificate of Analysis viewer for all formulary products
- [CME Programs](https://hempmd.org/cme): SABE Compliance Module and hemp medicine CME credits for physicians
- [Medical Board](https://hempmd.org/medical-board): HempMD physician advisory board credentials and expertise

## Condition Guides

- [CBD for Chronic Pain](https://hempmd.org/conditions/pain): Neuropathic pain, back pain, musculoskeletal — evidence and dosing
- [CBD for Anxiety](https://hempmd.org/conditions/anxiety): Generalized anxiety, HPA axis, serotonin 5-HT1A receptor mechanism
- [CBD for Sleep](https://hempmd.org/conditions/sleep): Insomnia, sleep architecture, circadian dysregulation
- [CBD for Cancer Symptoms](https://hempmd.org/conditions/cancer): Nausea, appetite, oncology pain management
- [CBD for Inflammation](https://hempmd.org/conditions/inflammation): Rheumatoid arthritis, osteoarthritis, systemic inflammation
- [CBD for Neurological Conditions](https://hempmd.org/conditions/neurological): Epilepsy, Dravet syndrome, Lennox-Gastaut syndrome, seizure disorders

## Formulary Products

- HMD-P01 — CBD Pain Relief Formula: Full-spectrum sublingual oil, 50mg CBD/1ml
- HMD-I02 — Joint & Inflammation Support: High-potency transdermal patch, 1000mg CBD/30ml
- HMD-S03 — Sleep Support Complex: Softgel capsule with CBD, CBN, CBG
- HMD-A04 — Calm & Stress Response Formula: Broad-spectrum sublingual oil, 33mg CBD/1ml

## Editorial Standards

- All clinical content reviewed by a licensed, board-certified physician
- No undisclosed commercial relationships with CBD brands
- All product recommendations cite third-party COA lab results
- No clinical claims without peer-reviewed citations
- HIPAA-compliant platform (PHI protected, BAA available)

## Contact

- General: care@hempmd.org
- Press: press@hempmd.org
- Physician credentialing: physicians@hempmd.org
- Social: facebook.com/hempmd · x.com/hempmd